Search Results
Aug 10, 2026, 11:45 ET Chrysler Showcases Two Custom Pacifica Concepts That Reimagine Minivan Practicality for More Lifestyles
and 21-inch wheels to create a custom look straight from the factory.Highlights include:21-inch Geode wheels with 245/45R21 Pirelli PZero summer tiresBlack-painted brake calipers1-inch lowered ride height for a more planted appearanceRed seat belts,
More news about: Stellantis
Aug 10, 2026, 11:00 ET InventHelp Inventor Develops Gutter Guard System for R-Panel Roofs (AFD-145)
provides a new gutter guard system for use with R-panel roofs. In doing so, it allows flow of water to drain with no hesitation. It also eliminates the need for extra straps on the gutters. As a result, it helps maintain the look and appearance of the R-panel roof. The invention features an effective
More news about: InventHelp
Aug 10, 2026, 11:00 ET STORMCRAFT PC Joins Intel Gamer Days 2026 With 29 Qualifying Gaming PCs, Launches New Intel Core Ultra 7 Systems Featuring GeForce RTX 5090, 5080 and 5070 Founders Edition Graphics
https://www.reddit.com/r/STORMCRAFTPC/
More news about: STORMCRAFT PC
Aug 10, 2026, 10:15 ET Khloud Expands Functional Snack Line, Introduces Khloud Plus: Protein Chips with Collagen
functionality to our Protein Chips without compromising the taste, texture, or crunch consumers already love," said Olivia Weihe, Senior Director of R&D at Khloud. "By formulating with hydrolyzed collagen - a highly digestible form of collagen - we created a snack that brings together two complementary
More news about: Khloud
Aug 10, 2026, 09:29 ET LIGHTALL Expands Global LED Display Footprint with One-Stop Solutions and Project Delivery Capabilities
functions.Building Global Partnerships Through Manufacturing and Service CapabilitiesAs a China LED display manufacturer integrating R&D, production and global service capabilities, LIGHTALL continuously invests in product optimization and technological innovation, and constantly improves
More news about: Shenzhen Lightall Optoelectronic Technology Co. Ltd
Aug 10, 2026, 08:32 ET LIMPID Selected for Korea's Deep-Tech TIPS Program, Expanding Government-Backed R&D Behind Kinfora to US$6 Million
been selected for Deep-Tech TIPS, the flagship startup R&D track of South Korea's Ministry of SMEs and Startups, securing KRW 1.5 billion (approximately US$1.1 million) over 36 months through June 2029. The award brings the government-backed R&D programs behind Kinfora to KRW 8.3 billion (US$6.0
More news about: LIMPID Corp.
Aug 10, 2026, 08:30 ET Theravance Biopharma, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update
million which represented a 7% increase compared to the same period in 2025.Research and Development (R&D) Expenses: R&D expenses for the second quarter of 2026 were $4.7 million, compared to $10.5 million in the same period in 2025. The reduction was driven
More news about: Theravance Biopharma, Inc.
Aug 10, 2026, 08:01 ET Acurx Announces Scientific Partnership with Leiden University Medical Center to Advance Development of Acurx's DNA Polymerase IIIC Inhibitor Antibiotics
Gram+ specific bacterial enzyme DNA polymerase IIIC (pol IIIC), inhibiting DNA replication and leading to Gram-positive bacterial cell death. Its R&D pipeline includes antibiotic product candidates that target Gram-positive bacteria, including Clostridioides difficile, methicillin- resistant Staphylococcus
More news about: Acurx Pharmaceuticals, Inc.
Aug 10, 2026, 08:00 ET Acarix Receives Regulatory Approval for the CADScor® System in the UAE (United Arab Emirates)
least 96% negative predictive value at point of care. The CADScor System has been used in over 60,000 patient assessments, is built on 15+ years of R&D covered by 45 patents, is CE-marked in accordance with EU MDR 2017/745, and has received FDA De Novo clearance as a diagnostic aid for symptomatic
More news about: Acarix
Aug 10, 2026, 07:00 ET 歌禮宣布在美國啟動兩項治療肥胖症的I期研究:胰澱素受體激動劑多肽月注射劑ASC36、ASC36和GLP-1R/GIPR激動劑多肽ASC35的復方月注射劑ASC36_35FDC
復方制劑;ASC39,一款與eloralintide類似、強效且對胰澱素具有選擇性的每日一次口服小分子胰澱素受體激動劑(SARA);ASC30_39FDC,一款每日一次口服小分子雙靶點激動劑,為ASC30(GLP-1R激動劑)與ASC39(胰澱素選擇性受體激動劑(SARA))的固定劑量復方制劑;ASC36,一款胰澱素多肽,設計為每月一次至每季度一次皮下注射以及每日一次口服;ASC35,一款每月一次皮下注射GLP-1R/GIPR雙靶點激動劑多肽;ASC36_35FDC,一款每月一次皮下注射三靶點多肽激動劑,為ASC36(胰澱素受體激動劑)與ASC35(GLP-1R/GIPR激動劑)的固定劑量復方制劑;ASC37,一款GLP-1R/GIPR/GCGR三靶點激動劑多肽,設計為每月一次皮下注射及每日一次口服;以及ASC36_37FDC,一款每月一次皮下注射四靶點激動劑多肽,為ASC36(胰澱素受體激動劑)與ASC37(GLP-1R/GIPR/GCGR激動劑)的固定劑量復方制劑,用於長期體重管理。歌禮已在香港聯交所上市(1672.HK)。
More news about: 歌禮製藥有限公司
Aug 10, 2026, 07:00 ET Ascletis Announces Initiation of Two Phase I Studies in U.S. for the Treatment of Obesity: ASC36 Once-Monthly Injection, an Amylin Receptor Peptide Agonist, and ASC36_35FDC Once-Monthly Injection, a Co-Formulation of ASC36 and GLP-1R/GIPR Peptide Agonist ASC35
ASC35, a once-monthly subcutaneously administered GLP-1R/GIPR dual peptide agonist, ASC36_35FDC, a once-monthly subcutaneous triple peptide agonist, a fixed combination of ASC36 (amylin receptor agonist) and ASC35 (GLP-1R/GIPR agonist), ASC37, a GLP-1R/GIPR/GCGR triple peptide agonist, designed to be administered
More news about: Ascletis Pharma Inc.
Aug 10, 2026, 06:45 ET Chemours Launches Opteon™ ZE and Opteon™ 515B Refrigerants for Chiller Applications Powering Data Centers, Commercial Buildings, and Other Mission Critical Environments
Opteon™ 515B (R-515B) is a zero ODP refrigerant blend consisting of approximately 91.1% R-1234ze(E) and 8.9% R-227ea. Featuring a GWP of approximately 293 (AR4) and an ASHRAE A1 classification (no flame propagation).
More news about: The Chemours Company
Aug 10, 2026, 06:34 ET Scinai Strengthens CDMO Leadership with Appointment of Eran Kuratz as Head of Supply Chain and Business Process Administration
between its sites and functions; the scalability of its operations; continued development and growth of its CDMO platform; and advancement of its R&D activities.These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause
More news about: Scinai Immunotherapeutics Ltd.
Aug 10, 2026, 05:00 ET Industrial Tires Market to Reach USD 12.44 Billion by 2035 Says Radial Insights
research and development.Recent Industry DevelopmentsIn January 2026, Michelin launched the XTRA POWER L5** 26.5 R25 for high-capacity loaders operating in mines and quarries. The new size addresses heavier equipment, higher torque requirements, operator comfort and
More news about: Radial Insights
Aug 10, 2026, 04:25 ET ASPEED Technology Joins OCP APAC Summit to Showcase Next-Generation OBMF Open Server Management Architecture and OpenPRoT Platform Security Architecture
Satellite Management Controllers (SMC), I/O Expanders, and Platform Root of Trust (PRoT) SoCs. Over the years, ASPEED has been dedicated to innovative R&D to swiftly address customer demands. In 2016, the company acquired Broadcom's Emulex Pilot™ BMC business, solidifying its position as the world's No.
More news about: ASPEED Technology Inc.
Aug 10, 2026, 04:08 ET ROHMs neues Terahertz-Oszillationsbauelement der zweiten Generation liefert eine viermal höhere Ausgangsleistung
https://cdn.kyodonewsprwire.jp/prwfile/release/M106254/202608033600/_prw_PI3fl_R0bRpfc7.jpgOffizielle Website: https://www.rohm.com/
More news about: ROHM Co., Ltd.
Aug 10, 2026, 03:20 ET Dragon Power unleashed: Minesto's Tidal Energy Power Plant sets electricity production record over summer
https://news.cision.com/minesto-ab/r/dragon-power-unleashed--minesto-s-tidal-energy-power-plant-sets-electricity-production-record-over-s,c4381466The following files are available for download:
More news about: Minesto AB
Aug 10, 2026, 03:17 ET Dragon Power unleashed: Minesto's Tidal Energy Power Plant sets electricity production record over summer
https://news.cision.com/minesto-ab/r/dragon-power-unleashed--minesto-s-tidal-energy-power-plant-sets-electricity-production-record-over-s,c4381466The following files are available for download:
More news about: Minesto AB
Aug 10, 2026, 03:10 ET Share buybacks in Ericsson during the period August 3 - August 7, 2026
https://news.cision.com/ericsson/r/share-buybacks-in-ericsson-during-the-period-august-3---august-7--2026,c4381365The following files are available for download:
More news about: Ericsson
Aug 10, 2026, 03:05 ET Share buybacks in Ericsson during the period August 3 - August 7, 2026
https://news.cision.com/ericsson/r/share-buybacks-in-ericsson-during-the-period-august-3---august-7--2026,c4381365The following files are available for download:
More news about: Ericsson
Aug 10, 2026, 03:00 ET Acwa Field Services przejmuje segment działalności spółki EthosEnergy obejmujący usługi w zakresie turbin parowych w Polsce, stawiając pierwszy krok na europejskim rynku usług serwisowych
sektorze usług terenowych.RIJAD, Arabia Saudyjska, 10 sierpnia 2026 r. /PRNewswire/ -- Acwa Field Services, podmiot odpowiedzialny za segment terenowych usług utrzymania i obsługi technicznej należący do notowanej na
More news about: Acwa
Aug 10, 2026, 03:00 ET Coway gibt Finanzergebnisse für das zweite Quartal des Geschäftsjahres 2026 bekannt
vorangetrieben. In diesem Quartal ist es BEREX gelungen, seine Position auf dem heimischen Sleep-Tech-Markt mit innovativen neuen Produkten wie dem „BEREX R Series Stretching Motion Bed" und dem „BEREX M Series Massagebett" weiter auszubauen. Darüber hinaus führte die Erweiterung des Mietportfolios von Coway
More news about: Coway Co., Ltd.
Aug 10, 2026, 03:00 ET Coway publie ses résultats financiers du deuxième trimestre 2026
BEREX a réussi à renforcer sa présence sur le marché national des technologies du sommeil grâce à de nouveaux produits innovants tels que le « BEREX R Series Stretching Motion Bed » et le « BEREX M Series Massage Bed ». Par ailleurs, l'élargissement du portefeuille de location de Coway à de nouvelles
More news about: Coway Co., Ltd.
Aug 10, 2026, 02:36 ET Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma
https://news.cision.com/swedish-orphan-biovitrum-ab/r/sobi-enters-strategic-partnership-with-innate-pharma-to-license-lacutamab-in-t-cell-lymphoma,c4381405The following files are available for download:
More news about: Swedish Orphan Biovitrum AB